QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
NASDAQ:SLP

Simulations Plus - SLP Stock Forecast, Price & News

$40.59
+0.71 (+1.78%)
(As of 11/30/2022 05:19 PM ET)
Add
Compare
Today's Range
$39.16
$40.62
50-Day Range
$38.00
$51.16
52-Week Range
$35.18
$67.59
Volume
150,542 shs
Average Volume
123,609 shs
Market Capitalization
$823.90 million
P/E Ratio
66.54
Dividend Yield
0.60%
Price Target
$63.67

Simulations Plus MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
57.0% Upside
$63.67 Price Target
Short Interest
Bearish
7.90% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.42mentions of Simulations Plus in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$2.62 M Sold Last Quarter
Proj. Earnings Growth
15.87%
From $0.63 to $0.73 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.89 out of 5 stars

Computer And Technology Sector

64th out of 632 stocks

Computer Integrated Systems Design Industry

2nd out of 40 stocks

SLP stock logo

About Simulations Plus (NASDAQ:SLP) Stock

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Receive SLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter.

SLP Stock News Headlines

Contrasting Simulations Plus (NASDAQ:SLP) and SmartRent (NYSE:SMRT)
Simulations Plus (SLP) Lags Q4 Earnings Estimates
Simulations Plus Releases GastroPlus® Version 9.8.3
Simulations Plus, Inc. (SLP)
See More Headlines
Receive SLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter.

SLP Company Calendar

Last Earnings
1/06/2022
Ex-Dividend for 11/7 Dividend
10/28/2022
Dividend Payable
11/07/2022
Today
11/30/2022
Next Earnings (Estimated)
1/05/2023
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Current Symbol
NASDAQ:SLP
Employees
135
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$63.67
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$56.00
Forecasted Upside/Downside
+56.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$12.48 million
Pretax Margin
28.04%

Debt

Sales & Book Value

Annual Sales
$53.91 million
Cash Flow
$0.91 per share
Book Value
$8.81 per share

Miscellaneous

Free Float
15,613,000
Market Cap
$823.90 million
Optionable
Optionable
Beta
0.46

Social Links


Key Executives

  • Mr. Walter S. Woltosz M.A.S.Mr. Walter S. Woltosz M.A.S. (Age 77)
    M.S., Co-Founder & Chairman
    Comp: $91.04k
  • Mr. Shawn M. O'Connor (Age 62)
    Chief Exec. Officer
    Comp: $544.23k
  • Mr. John Anthony DiBella M.S. (Age 42)
    Pres
    Comp: $312.15k
  • Mr. William Frederick (Age 58)
    CFO & Sec.
    Comp: $371.7k
  • Dr. Brett A. Howell Ph.D. (Age 38)
    Pres of DILIsym Services, Inc
    Comp: $249.35k
  • Ms. Jill Fiedler-Kelly M.S. (Age 52)
    MS, Pres of Cognigen Division
    Comp: $251.89k
  • Ms. Viera Lukacova Ph.D.
    Chief Scientific Officer
  • Dr. Bud Nelson J.D.
    Ph.D., VP of Corp. Counsel & Personal Data Protection Officer
  • Ms. Arlene Padron
    Corp. Director of Marketing
  • Ms. Lindsay Luke
    Exec. Director of HR













SLP Stock - Frequently Asked Questions

Should I buy or sell Simulations Plus stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SLP shares.
View SLP analyst ratings
or view top-rated stocks.

What is Simulations Plus' stock price forecast for 2023?

3 analysts have issued 12-month price objectives for Simulations Plus' stock. Their SLP share price forecasts range from $56.00 to $70.00. On average, they anticipate the company's share price to reach $63.67 in the next twelve months. This suggests a possible upside of 61.2% from the stock's current price.
View analysts price targets for SLP
or view top-rated stocks among Wall Street analysts.

How have SLP shares performed in 2022?

Simulations Plus' stock was trading at $47.30 at the start of the year. Since then, SLP stock has decreased by 16.5% and is now trading at $39.50.
View the best growth stocks for 2022 here
.

When is Simulations Plus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 5th 2023.
View our SLP earnings forecast
.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) released its quarterly earnings results on Thursday, January, 6th. The technology company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.04. The technology company had revenue of $12.42 million for the quarter, compared to the consensus estimate of $11.17 million. Simulations Plus had a net margin of 23.24% and a trailing twelve-month return on equity of 7.36%. During the same period in the prior year, the business posted $0.12 EPS.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Thursday, October 20th. Stockholders of record on Monday, October 31st will be given a dividend of $0.06 per share on Monday, November 7th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date is Friday, October 28th.
Read our dividend analysis for SLP
.

Is Simulations Plus a good dividend stock?

Simulations Plus (NASDAQ:SLP) pays an annual dividend of $0.24 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 39.34%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SLP will have a dividend payout ratio of 32.88% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SLP.

What guidance has Simulations Plus issued on next quarter's earnings?

Simulations Plus updated its FY 2023 earnings guidance on Wednesday, November, 2nd. The company provided earnings per share guidance of $0.63-$0.67 for the period, compared to the consensus estimate of $0.71. The company issued revenue guidance of $59.30 million-$62.00 million, compared to the consensus revenue estimate of $62.35 million.

What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), NVIDIA (NVDA), Verizon Communications (VZ), CVS Health (CVS), Enterprise Products Partners (EPD), AbbVie (ABBV) and Pfizer (PFE).

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

Who are Simulations Plus' major shareholders?

Simulations Plus' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.51%), Conestoga Capital Advisors LLC (10.85%), Neuberger Berman Group LLC (7.57%), Vanguard Group Inc. (5.55%), State Street Corp (2.73%) and Royce & Associates LP (1.45%). Insiders that own company stock include David L Ralph, John Anthony Dibella II, John Kenneth Paglia, Lisa Lavange, Shawn Oconnor, Walter S Woltosz and Walter S Woltosz.
View institutional ownership trends
.

How do I buy shares of Simulations Plus?

Shares of SLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $39.50.

How much money does Simulations Plus make?

Simulations Plus (NASDAQ:SLP) has a market capitalization of $801.85 million and generates $53.91 million in revenue each year. The technology company earns $12.48 million in net income (profit) each year or $0.61 on an earnings per share basis.

How many employees does Simulations Plus have?

The company employs 135 workers across the globe.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The official website for the company is www.simulations-plus.com. The technology company can be reached via phone at (661) 723-7723, via email at investors@westerngas.com, or via fax at 661-723-5524.

This page (NASDAQ:SLP) was last updated on 11/30/2022 by MarketBeat.com Staff